Share
Despite political and economic uncertainties, healthcare remains a lucrative investment space. However, growing concerns around government spending cuts on Medicare, Medicaid, and medical research could impact investment flows. Additionally, tariffs and high interest rates may influence deal valuations and financing conditions. Despite these risks, experts believe healthcare's fundamental value proposition—driven by necessity and innovation—will keep it attractive to investors in the long run.
Rob Larson was interviewed by Termgrid and shared his thoughts on the role and value of tech-enabled services, as well as some thoughts on the overall state of the market.
Read More
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Miriam El-Baz and Connor Novy were recognized at the Consulting Magazine Women Leaders awards to highlight the outstanding contributions made by women in consulting. Read more.
Financier Worldwide discusses strategy & execution for accelerating value in carve-outs with Phil Dunne and Peter Rodrigues-Renon at Stax, including Gerard Nichol at Grant Thornton. Read more.
Investment focus in automotive technology continues to broaden beyond OEMs to the core service ecosystem. Read what Sameer Tejani and Max Massaro see in the market.
Grant Thornton Stax supported SteelEye, a leading trade and communications surveillance and data analytics platform, on its recent merger with FundApps. Read about the deal here.